Search
Mozafancogene autotemcel
go.drugbank.com/drugs/DB17723InvestigationalRP-L102 is a lentiviral vector carrying the Fanconi Anemia-A (FANCA) gene currently being developed by Rocket Pharmaceuticals for the treatment of Fanconi anemia type A
Synonyms: Autologous CD34+-enriched Hematopoietic Stem and Progenitor Cells Transduced with Lentiviral Vector Carrying FANCA Gene RP-L102Niacin
go.drugbank.com/drugs/DB00627ApprovedInvestigationalNutraceuticalNiacin is a B vitamin used to treat vitamin deficiencies as well as hyperlipidemia, dyslipidemia, hypertriglyceridemia, and to reduce the risk of myocardial infarctions.
Mixtures: Luna Vitamin and Mineral Bar for Women, Folivane-Plus with Ascorbic Acid PrecursorsCategories: Nicotinic Acid and Derivatives, lovastatin and nicotinic acidL-N(omega)-nitroarginine-(4R)-amino-L-proline amide
go.drugbank.com/drugs/DB02077ExperimentalSynonyms: L-N(omega)-nitroarginine-(4R)-amino-L-proline amideLamivudine
go.drugbank.com/drugs/DB00709ApprovedInvestigationalA reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. … It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV).
Mixtures: Zidovex L (Lamivudine 150mg and Zidovudine 300mg Tablets), Lamivudine and ZidovudineCategories: Nucleic Acids, Nucleotides, and Nucleosides, Nucleic Acid Synthesis InhibitorsSulfamethoxazole
go.drugbank.com/drugs/DB01015ApprovedInvestigationalin the biosynthesis of nucleic acids and proteins which are necessary for bacterial growth and division, and using them in conjunction helps to slow the development of bacterial resistance. … [L11830] In this combination, sulfamethoxazole is useful for the treatment of a variety of bacterial infections, including those of the urinary, respiratory, and gastrointestinal tracts.
Mixtures: BAK-TRI-ZOL, BAKTROL TABLET, 30 ADETCategories: Sulfonamides and trimethoprim, sulfamethoxazole and trimethoprimPacmilimab
go.drugbank.com/drugs/DB18873InvestigationalPacmilimab is under investigation in clinical trial NCT04596150 (Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer).
Synonyms: IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH-LIGAND 1) (HUMAN MONOCLONAL CX-072 .GAMMA.4-CHAIN), DISULFIDE WITH PRODOMAIN PROTEIN (SYNTHETIC MASKING MOIETY AND CLEAVABLE MOIETY PROTEASE SUBSTRATE-CONTAINING, ) FUSION PROTEIN WITH HUMAN MONOCLONAL CBazlitoran
go.drugbank.com/drugs/DB14990InvestigationalBazlitoran is under investigation in clinical trial NCT02092909 (Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia).
Categories: Nucleic Acids, Nucleotides, and NucleosidesSynonyms: Antagonist of the endosomal Toll-like receptors (TLRs) 7, 8, and 9, ALL-P-AMBO-2'-DEOXY-P-THIOCYTIDYLYL-(3'->5')-P-THIOTHYMIDYLYL-(3'->5')-2'-DEOXY-P-THIOADENYLYL-(3'->5')-P-THIOTHYMIDYLYL-(3'->5')-2'-DEOXY-P-THIOCYTIDYLYL-(3'->5')-P-THIOTHYMIDYLYL-(3'->5')-2'-O-METHYL-P-THIOGUANYLYL1,2-icosapentoyl-sn-glycero-3-phosphoserine
go.drugbank.com/drugs/DB14096ApprovedSalts: 1,2-icosapentoyl-sn-glycero-3-phosphoserine calciumSynonyms: 1,2-icosapentoyl-sn-glycero-3-phosphoserineBordetella pertussis fimbriae 2/3 antigen
go.drugbank.com/drugs/DB10790ApprovedInvestigationalfimbriae (Fim2 and Fim3). … Bordetella pertussis fimbriae 2/3 antigen is a vaccine for the prophylaxis of the disease caused by Bordetella pertussis which is a a Gram-negative coccobacillus that expresses two serologically distinct
Mixtures: INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and, BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGENSynonyms: Bordetella pertussis fimbriae 2/3 antigen, Bordetella pertussis fimbriae 2/3 vaccine, inactivatedEfzofitimod
go.drugbank.com/drugs/DB16453InvestigationalIt is a selective modulator of neuropilin-2 that downregulates the innate and adaptive immune response in inflammatory disease states. … Efzofitimod (ATYR1923) is a fusion protein comprised of the immuno-modulatory domain of histidyl tRNA synthetase fused to the FC region of a human antibody.
Synonyms: Human IgG1Fc- iMod domain (amino acids 2-60) of human HARS fusion protein